Corbus Pharmaceuticals Holdings - stock earnings
CRBP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -8.0 million USD | ? USD |
| 2023Q3 | -10.1 million USD | ? USD |
| 2023Q2 | -8.8 million USD | ? USD |
| 2023Q1 | -18.7 million USD | ? USD |
| 2022Q4 | -10.9 million USD | ? USD |
| 2022Q3 | -9.0 million USD | ? USD |
| 2022Q2 | -24.9 million USD | ? USD |
| 2022Q1 | -11.1 million USD | ? USD |
| 2021Q4 | -10.3 million USD | -233881 USD |
| 2021Q3 | -2.2 million USD | 97323 USD |
| 2021Q2 | -17.1 million USD | 136558 USD |
| 2021Q1 | -16.1 million USD | 647824 USD |
| 2020Q4 | -8.6 million USD | 658204 USD |
| 2020Q3 | -34.9 million USD | 1.2 million USD |
| 2020Q2 | -38.1 million USD | 286346 USD |
| 2020Q1 | -29.7 million USD | 1.8 million USD |
| 2019Q4 | -26.6 million USD | 2.6 million USD |
| 2019Q3 | -20.8 million USD | 2.6 million USD |
| 2019Q2 | 2.2 million USD | 29.1 million USD |
| 2019Q1 | -26.2 million USD | 1.9 million USD |
| 2018Q4 | -17.3 million USD | 1.9 million USD |
| 2018Q3 | -14.6 million USD | 1.1 million USD |
| 2018Q2 | -12.1 million USD | 853646 USD |
| 2018Q1 | -11.7 million USD | 950442 USD |
| 2017Q4 | -10.7 million USD | -2.4 million USD |
| 2017Q3 | -7.0 million USD | 796312 USD |
| 2017Q2 | -7.3 million USD | 350186 USD |
| 2017Q1 | -7.5 million USD | 1.3 million USD |
| 2016Q4 | -7.6 million USD | 375670 USD |
| 2016Q3 | -5.3 million USD | 742558 USD |
| 2016Q2 | -4.2 million USD | 396598 USD |
| 2016Q1 | -2.9 million USD | 396598 USD |
| 2015Q4 | -2.5 million USD | 364292 USD |
| 2015Q3 | -2.3 million USD | 170454 USD |
| 2015Q2 | -2.6 million USD | 113636 USD |
| 2015Q1 | -1.5 million USD | ? USD |
| 2014Q4 | -1.3 million USD | ? USD |
| 2014Q3 | -659621 USD | ? USD |
| 2014Q2 | -504608 USD | ? USD |
| 2014Q1 | -115979 USD | ? USD |
| 2013Q4 | -289878 USD | ? USD |
| 2013Q3 | -59552 USD | ? USD |
CRBP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -44.6 million USD | ? USD |
| 2022 | -55.8 million USD | ? USD |
| 2021 | -45.6 million USD | 881705 USD |
| 2020 | -111.3 million USD | 3.9 million USD |
| 2019 | -69.2 million USD | 36.1 million USD |
| 2018 | -55.7 million USD | 4.8 million USD |
| 2017 | -32.4 million USD | 2.4 million USD |
| 2016 | -20.0 million USD | 1.9 million USD |
| 2015 | -8.9 million USD | 648382 USD |
| 2014 | -2.5 million USD | ? USD |
| 2013 | -602350 USD | ? USD |
CRBP
Price: $38.77
52 week price:
Earnings Per Share: -10.31 USD
P/E Ratio: -2.35
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.8 million
Ebitda: -6.8 millionMarket Capitalization: 419.4 million